DelphX Announces Closing of Non-Brokered Unit Private Placement
DelphX (OTCQB: DPXCF; TSXV: DELX) closed a non-brokered unit private placement announced Nov 27, 2025, issuing 2,800,000 units at C$0.04 per unit for gross proceeds of C$112,000.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
DelphX (OTCQB: DPXCF; TSXV: DELX) closed a non-brokered unit private placement announced Nov 27, 2025, issuing 2,800,000 units at C$0.04 per unit for gross proceeds of C$112,000. Each unit comprises one common share and one warrant.
Each warrant allows purchase of one common share at $0.07 for two years from issuance. Completion remains subject to TSX Venture Exchange approval. Securities are subject to a four-month plus one day hold period. DelphX intends to use net proceeds for working capital and corporate overhead.
Positive
- Gross proceeds C$112,000 raised for working capital
- Units include common share plus one warrant, offering structured investor incentive
Negative
- 2,800,000 warrants exercisable at $0.07 for two years create potential dilution
- Offering completion is subject to TSXV approval, so issuance is not final
- C$112,000 gross proceeds represent a relatively small funding amount
Details
News Market Reaction – DPXCF
On Dec 17, the first trading day after this news, DPXCF closed 8.14% above the previous close.
Data tracked by StockTitan Argus for the Dec 17 session.
Key Figures
- Units issued
- 2,800,000 units
- Non-brokered private placement closing on Dec 2, 2025
- Unit price
- C$0.04 per unit
- Subscription price in this offering
- Gross proceeds
- C$112,000
- Total raised in this non-brokered placement
- Warrant exercise price
- $0.07 per share
- Exercise price for each attached warrant
- Warrant term
- 2 years
- Exercise period from date of issuance
- Hold period
- 4 months plus 1 day
- Resale restriction on securities issued
- Price change
- -7.81%
- Move prior to this news vs previous close
- 52-week range
- $0.0295–$0.1653
- Current price at 52-week low; 82.15% below high
Historical Context
-
Closed non-brokered placement of 1.2M units for C$60,000.
-
Announced intent for 1.2M-unit non-brokered private placement.
-
Planned extension of 3.48M warrants exercisable at $0.20.
-
Sought to extend two warrant series totaling over 7.6M warrants.
-
Outlined new private placement marketing and crypto product initiatives.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
non-brokered private placement financial
unit private placement financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
Toronto, Ontario--(Newsfile Corp. - December 2, 2025) - DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) ("DelphX"), a leader in the development of new classes of structured products, announces that it has closed its non-brokered private placement previously announced on November 27, 2025, issuing 2,800,000 units (the "Units") at a subscription price of C
Completion of the Offering is subject to the approval of the TSX Venture Exchange. The securities issued pursuant to the Offering will be subject to a hold period of four months plus one day from the date of issuance.
DelphX intends to use the net proceeds from the Offering in connection with working capital/corporate overhead.
About DelphX Capital Markets Inc.
DelphX is a technology and financial services company focused on developing and distributing the next generation of structured products. Through its special purpose vehicle Quantem LLC, the Company enables broker dealers to offer new private placement securities that provide for both fixed income and cryptocurrency solutions. The new DelphX securities will enable dealers and their qualified institutional investors (QIBs) accounts to competitively structure, sell and make markets in:
- Collateralized put options (CPOs) that provide secured rating downgrade protection for underlying corporate bonds and/or protection from losses in cryptocurrency holdings;
- Collateralized reference notes (CRNs) that enable investors to take on a capped rating downgrade and/or cryptocurrency loss exposure of an underlying security or cryptocurrency in exchange for attractive returns.
All CPOs and CRNs are fully collateralized and held in custody by US Bank. CPOs and CRNs are proprietary products created and owned by DelphX Capital Markets.
For more information about DelphX, please visit www.delphx.com
George Wentworth, General Manager
DelphX Capital Markets Inc.
george.wentworth@delphx.com
(718) 509-2160
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/276707
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.